Document Detail


Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes.
MedLine Citation:
PMID:  20655299     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The niacin receptor GPR109A is a G(i)-protein-coupled receptor which mediates the effects of niacin on inhibiting intracellular triglyceride lipolysis in adipocytes. However, the role of GPR109A in mediating the effects of niacin on high density lipoprotein (HDL) metabolism is unclear. We found niacin has no effect on HDL-C in GPR109A knockout mice. Furthermore, niacin lowered intracellular cAMP in primary hepatocytes mediated by GPR109A. We used an adeno-associated viral (AAV) serotype 8 vector encoding GPR109A under the control of the hepatic-specific thyroxine-binding globulin promoter to specifically overexpress GPR109A in mouse liver. Plasma HDL-C, hepatic ABCA1 and the HDL cholesterol production rate were significantly reduced in mice overexpressing GPR109A. Overexpression of GPR109A reduced primary hepatocyte free cholesterol efflux to apoA-I; conversely, GPR109A deficient hepatocytes had increased ABCA1-mediated cholesterol efflux. These data support the concept that the HDL-C lowering effect of niacin in wild-type mice is mediated through stimulation of GPR109A in hepatocytes; such an effect then leads to reduced hepatocyte ABCA1 expression and activity, decreased cholesterol efflux to nascent apoA-I, and reduced HDL-C levels. These results indicate that niacin-mediated activation of GP109A in liver lowers ABCA1 expression leading to reduced hepatic cholesterol efflux to HDL.
Authors:
Xiaoyu Li; John S Millar; Nicholas Brownell; François Briand; Daniel J Rader
Related Documents :
990299 - Relationship between cell size, plasma cholesterol and rat adipocyte cholesterol storage.
9888879 - Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with ...
15210959 - Atp-binding cassette transporters g1 and g4 mediate cellular cholesterol efflux to high...
16606609 - Mechanism of cholesterol transfer from the niemann-pick type c2 protein to model membra...
20122819 - Analysis of the 22-nbd-cholesterol transfer between liposome membranes and its relation...
17428449 - Altered cholesterol metabolism in app695-transfected neuroblastoma cells.
7370219 - Estimation of body fat in normal and obese mice.
19662759 - Dyslipidemia and adherence to the mediterranean diet in croatian hiv-infected patients ...
3689479 - The hyperlipidemic hamster as a model of experimental atherosclerosis.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2010-07-22
Journal Detail:
Title:  Biochemical pharmacology     Volume:  80     ISSN:  1873-2968     ISO Abbreviation:  Biochem. Pharmacol.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-09-20     Completed Date:  2010-10-06     Revised Date:  2012-04-20    
Medline Journal Info:
Nlm Unique ID:  0101032     Medline TA:  Biochem Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1450-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Affiliation:
Institute for Translational Medicine and Therapeutics and Cardiovascular Institute, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
ATP-Binding Cassette Transporters / metabolism
Animals
Apolipoprotein A-I / metabolism
Cells, Cultured
Cholesterol / metabolism
Cholesterol, HDL / blood
Cyclic AMP / metabolism
Female
Hepatocytes / metabolism*
Lipopolysaccharides / pharmacology
Lipoproteins, HDL / metabolism*
Mice
Mice, Inbred C57BL
Mice, Knockout
Niacin / pharmacology
Receptors, G-Protein-Coupled / physiology*
Receptors, Nicotinic / physiology*
Grant Support
ID/Acronym/Agency:
P50 HL083799-04/HL/NHLBI NIH HHS; P50-HL-083799/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/ATP binding cassette transporter 1; 0/ATP-Binding Cassette Transporters; 0/Apolipoprotein A-I; 0/Cholesterol, HDL; 0/Hcar2 protein, mouse; 0/Lipopolysaccharides; 0/Lipoproteins, HDL; 0/Receptors, G-Protein-Coupled; 0/Receptors, Nicotinic; 57-88-5/Cholesterol; 59-67-6/Niacin; 60-92-4/Cyclic AMP

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  XIAP is essential for shear stress-enhanced Tyr-576 phosphorylation of FAK.
Next Document:  Influence of brain-derived neurotrophic factor (val66met) genetic polymorphism on the ages of onset ...